RFL Rafael Holdings, Inc.
$1.99
Rafael Holdings, Inc. (RFL) is expected to report earnings on September 10, 2026, after the market close.
Rafael Reported Earnings
Thursday, June 11, 2026 · 7:30 AM ET
Earnings Date
Sep 10
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Rafael Holdings, Inc.
Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.
Sector
Healthcare